Results 1 to 10 of about 4,991,692 (213)

Vogt-Koyanagi-Harada Disease Exacerbation Associated with COVID-19 Vaccine

Cells, 2022
We describe a case of Vogt-Koyanagi-Harada (VKH) disease exacerbation after COVID-19 vaccination. A 46-year-old woman presented with a bilateral granulomatous uveitis 2 days after the first dose of COVID-19 mRNA vaccine (Comirnaty, Pfizer-BioNTech), and ...
Begoña De Domingo, Miguel López, Maria Lopez-Valladares, Esperanza Ortegon-Aguilar, Bernardo Sopeña-Perez-Argüelles, Francisco Gonzalez   +5 more
doaj   +3 more sources

Vogt‐Koyanagi‐Harada disease‐like uveitis induced by nivolumab in metastatic renal cell carcinoma [PDF]

IJU Case Reports
Introduction Nivolumab can cause various immune‐related adverse events; it rarely induces Vogt‐Koyanagi‐Harada‐disease‐like uveitis. Vogt‐Koyanagi‐Harada‐disease is reported to be closely associated with human leukocyte antigen‐DR4.
Hitomi Imai, Tomoyuki Koguchi, Yuki Harigane, Kei Yaginuma, Satoru Meguro, Seiji Hoshi, Junya Hata, Hidenori Akaihata, Soichiro Ogawa, Yoshiyuki Kojima   +9 more
doaj   +3 more sources

Vogt‐Koyanagi‐Harada disease in pregnancy: Case report and review of 32 patients in the literature [PDF]

Clinical Case Reports
Key Clinical Message Systemic prednisolone including steroid pulse therapy would be safe in 32 pregnant women, who developed Vogt‐Koyanagi‐Harada disease in the literature.
Toshihiko Matsuo, Kasumi Takahashi, Tsunemasa Kondo   +2 more
doaj   +3 more sources

Vogt–Koyanagi–Harada disease recurrence after laser treatment: A case report [PDF]

Journal of International Medical Research
This study reports two cases of Vogt–Koyanagi–Harada disease recurrence after laser treatment. Case 1 involved a woman in her late 70s with Vogt–Koyanagi–Harada disease that was controlled by adalimumab and steroid eye solution therapy.
Tetsuya Muto, Masaaki Sakamoto, Shigeki Machida, Shinichiro Imaizumi, Tetsuju Sekiryu   +4 more
doaj   +2 more sources

A randomized non-inferiority trial of therapeutic strategy with immunosuppressants versus biologics for Vogt-Koyanagi-Harada disease

Nature Communications, 2023
Biologics are increasingly used to treat Vogt-Koyanagi-Harada disease, but head-to-head comparisons with conventional immunosuppressants are lacking.
Zhenyu Zhong, Lingyu Dai, Qiuying Wu, Yu Gao, Yanlin Pu, Guannan Su, Xiaorong Lu, Fuxiang Zhang, Chong Tang, Yao Wang, Chunjiang Zhou, Peizeng Yang   +11 more
doaj   +2 more sources

Alterations of the Enteric Virome in Vogt-Koyanagi-Harada Disease. [PDF]

Invest Ophthalmol Vis Sci
Purpose This study aims to explore the enteric virome characteristics of Vogt Koyanagi Harada (VKH) disease and its potential role in this disease. Methods Shotgun metagenomic sequencing was used to detect the enteric virome and 16S rRNA to detect the ...
Liu M, Geng J, Jin S, Hu P, Wang X, Liu X.   +5 more
europepmc   +2 more sources

Acute interstitial nephritis and probable Vogt–Koyanagi–Harada disease following COVID-19 infection: a case report [PDF]

Journal of Medical Case Reports
Introduction Vogt–Koyanagi–Harada disease is an autoimmune inflammatory disease characterized by bilateral serous retinal detachment, which viral infections might induce.
Nahid Aslani, Mohammad Malekahmadi, Alireza Merrikhi, Alaleh Gheisari, Aida Mardani, Kimia Afshar   +5 more
doaj   +2 more sources

Vogt‐Koyanagi‐Harada disease‐like posterior uveitis in the course of nivolumab (anti‐PD‐1 antibody), interposed by vemurafenib (BRAF inhibitor), for metastatic cutaneous malignant melanoma

Clinical Case Reports, 2017
Key Clinical Message A patient with metastatic cutaneous malignant melanoma developed Vogt‐Koyanagi‐Harada disease‐like posterior uveitis after two nivolumab (anti‐PD‐1 antibody) injections.
Toshihiko Matsuo, Osamu Yamasaki
doaj   +2 more sources

Systemic bias in medical consensus: how flawed panels and lack of evidence can distort definitions and guidelines: the case of Vogt-Koyanagi-Harada disease [PDF]

Journal of Ophthalmic Inflammation and Infection
Background The creation of diagnostic criteria for a disease is always challenging in medicine. Consensus meetings and expert’s opinions are sometimes responsible for establishing useful and precise diagnostic criteria but, unfortunately, not all the ...
Carl P. Herbort, Ioannis Papasavvas, Ahmed M. Abu El-Asrar, Abdulrahman F. AlBloushi, De-Kuang Hwang, Vania Lages, Wen-Jung Lo, Kazuich Maruyama, Piergiorgio Neri, Masaru Takeuchi, Yoshihiko Usui   +10 more
doaj   +2 more sources

Vogt-Koyanagi-Harada disease: Novel insights into pathophysiology, diagnosis and treatment

Progress in Retinal and Eye Research, 2016
Peizeng Yang
exaly   +2 more sources